Comparative Pharmacology
Head-to-head clinical analysis: OSMITROL 10 IN WATER versus OSMITROL 10 IN WATER IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: OSMITROL 10 IN WATER versus OSMITROL 10 IN WATER IN PLASTIC CONTAINER.
OSMITROL 10% IN WATER vs OSMITROL 10% IN WATER IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Osmotic diuretic that increases plasma osmolality, drawing water from intracellular spaces into extracellular fluid and increasing renal blood flow, thereby enhancing water excretion.
Increases plasma osmolality, drawing water from tissues into the bloodstream, thereby reducing intracranial pressure and cerebral edema.
0.25-2 g/kg intravenously over 30-60 minutes, repeated every 6-12 hours as needed. Maximum dose: 2 g/kg per dose or 200 g daily.
Initial: 0.25–1 g/kg (25–100 mL of 10% solution) IV over 30–60 minutes. May repeat every 6–12 hours if needed. Typical adult dose: 50–100 g IV. Maximum: 2 g/kg per dose.
None Documented
None Documented
Terminal elimination half-life is approximately 0.25–1.5 hours in patients with normal renal function, prolonged in renal impairment.
Terminal half-life approximately 1.5 hours in normal renal function; prolonged in renal impairment (up to 36 hours in anuria).
Renal: >90% excreted unchanged by glomerular filtration with minimal tubular reabsorption. Negligible biliary/fecal elimination.
Primarily renal; >90% excreted unchanged in urine via glomerular filtration; <5% biliary/fecal.
Category C
Category C
Osmotic Diuretic
Osmotic Diuretic